C23H34N2O7
Neat
450.53
remogliflozin; Remogliflozin A; 329045-45-6; UNII-13ZPK7A4MJ; 13ZPK7A4MJ; REMOGLIFLOZIN [WHO-DD]; beta-D-Glucopyranoside, 5-methyl-4-((4-(1-methylethoxy)phenyl)methyl)-1-(1-methylethyl)-1H-pyrazol-3-yl; DTXSID30186563; .BETA.-D-GLUCOPYRANOSIDE, 5-METHYL-4-((4-(1-METHYLETHOXY)PHENYL)METHYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-3-YL; RefChem:178832; DTXCID70109054; 2-(4-propan-2-yloxyphenyl)-1-(5-propan-2-yl-3-((2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-1H-pyrazol-4-yl)ethanone; 2-(4-propan-2-yloxyphenyl)-1-[5-propan-2-yl-3-[(2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-pyrazol-4-yl]ethanone; (2R, 3S, 4S, 5R, 6S)-2-(hydroxymethyl)-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxane-3, 4 and 5-triol; orb1702881; SCHEMBL2253397; CHEMBL3958686; GSINGUMRKGRYJP-VZWAGXQNSA-N; BDBM50559517; MFCD18452863
(2R, 3S, 4S, 5R, 6S)-2-(hydroxymethyl)-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxane-3, 4 and 5-triol
InChI=1S/C23H34N2O7/c1-12(2)25-14(5)17(10-15-6-8-16(9-7-15)30-13(3)4)22(24-25)32-23-21(29)20(28)19(27)18(11-26)31-23/h6-9,12-13,18-21,23,26-29H,10-11H2,1-5H3/t18-,19-,20+,21-,23+/m1/s1